首页>投融资
Artiva Biotherapeutics
上市
Artiva Biotherapeutics, owned by GC Pharma focuses on the development of cancer drugs based on NK cells.In March 2019, GC Pharma and affiliate GC LabCell had jointly established Artiva Biotherapeutics, a cell therapy development company.In June 2022, Artiva Biotherapeutics Inc announced the official opening of the U.S. corporate headquarters and R&D laboratory facilities at the Alexandria Tech Center in San Diego.In August 2021, Artiva Biotherapeutics Inc announced the expansion of its U.S. facilities in San Diego.In February 2021, Artiva Biotherapeutics announced the closing of a $120 million Series B financing.In June 2020, the company launched a $78 million Series A financing
基本信息
-
公司全称Artiva Biotherapeutics Inc
-
类型癌症治疗药物研发商
-
产业领域生物药、药品研发/制造、生物/化学技术
-
公司人数51~100人
-
地址5505 Morehouse Drive SAN DIEGO CALIFORNIA 92121; US; Telephone: +18582674467;
-
联系电话1-858-2674467
-
邮箱info@artivabio.com
-
成立时间2019-01-01
投融资
-
2024-07-19上市1.67亿美元未透露
-
2021-02-26B轮1.2亿美元Venrock CapitalGreen CrossGreen CrossVenBio PartnersRA Capital5AM VenturesWellington ManagementSurveyor CapitalRTW InvestmentsLogos CapitalJanus Henderson InvestorsFranklin Templeton InvestmentsEcoR1 Capital鱼鹰资管Acuta
-
2020-06-26A轮7800万美元Green CrossRA CapitalVenBio PartnersMedivate Partners5AM Ventures
相关投融资企业
上市
Artiva Biotherapeutics, owned by GC Pharma focuses on the development of cancer drugs based on NK cells.In March 2019, GC Pharma and affiliate GC LabCell had jointly established Artiva Biotherapeutics, a cell therapy development company.In June 2022, Artiva Biotherapeutics Inc announced the official opening of the U.S. corporate headquarters and R&D laboratory facilities at the Alexandria Tech Center in San Diego.In August 2021, Artiva Biotherapeutics Inc announced the expansion of its U.S. facilities in San Diego.In February 2021, Artiva Biotherapeutics announced the closing of a $120 million Series B financing.In June 2020, the company launched a $78 million Series A financing
B轮
Artiva Biotherapeutics, owned by GC Pharma focuses on the development of cancer drugs based on NK cells.In March 2019, GC Pharma and affiliate GC LabCell had jointly established Artiva Biotherapeutics, a cell therapy development company.In June 2022, Artiva Biotherapeutics Inc announced the official opening of the U.S. corporate headquarters and R&D laboratory facilities at the Alexandria Tech Center in San Diego.In August 2021, Artiva Biotherapeutics Inc announced the expansion of its U.S. facilities in San Diego.In February 2021, Artiva Biotherapeutics announced the closing of a $120 million Series B financing.In June 2020, the company launched a $78 million Series A financing
A轮
Artiva Biotherapeutics, owned by GC Pharma focuses on the development of cancer drugs based on NK cells.In March 2019, GC Pharma and affiliate GC LabCell had jointly established Artiva Biotherapeutics, a cell therapy development company.In June 2022, Artiva Biotherapeutics Inc announced the official opening of the U.S. corporate headquarters and R&D laboratory facilities at the Alexandria Tech Center in San Diego.In August 2021, Artiva Biotherapeutics Inc announced the expansion of its U.S. facilities in San Diego.In February 2021, Artiva Biotherapeutics announced the closing of a $120 million Series B financing.In June 2020, the company launched a $78 million Series A financing
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息